November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Non-Invasive Biomarker Panel May Help Classify Male Infertility Subtypes

❤️ Conditions & Care 2 min read 👁 6

Scientists have created a low-input fluid analysis method that identifies specific protein markers in seminal plasma to differentiate forms of azoospermia.

❤️Conditions & Care

Key points

  • Researchers developed EVGlyco, a workflow analyzing extracellular vesicle N-glycans from micro-volume biofluids.
  • Specific protein biomarker panels differentiated obstructive azoospermia from nonobstructive azoospermia with high diagnostic accuracy.
  • Selected N-glycan markers accurately distinguished three distinct subtypes of nonobstructive male infertility.

A new analytical testing approach using seminal plasma micro-samples may offer a non-invasive way to differentiate types of azoospermia, a severe form of male infertility characterized by a lack of sperm in ejaculated fluid, according to a study published in Nature Health Sciences by researchers from Nanjing Medical University, Southeast University, and Peking University.

The research team developed a molecular workflow named EVGlyco to isolate and examine site-specific sugar structures, known as N-glycans, attached to extracellular vesicle proteins in human biofluids. In an initial discovery evaluation using seminal plasma samples, the investigators identified 8,435 EV protein site-specific N-glycans.

Using targeted molecular validation, the study demonstrated that a biomarker panel consisting of MPO-N355-H6N2 and ACP3-N94-H5N4F1 distinguished obstructive azoospermia from nonobstructive azoospermia with an area under the curve value of 0.88. Additionally, markers CLU-N374-H10N9 and CLU-N374-H10N9F1 successfully separated three subtypes of nonobstructive azoospermia—hypospermatogenesis, maturation arrest, and Sertoli cell-only syndrome—achieving diagnostic accuracy scores of 0.86, 0.99, and 0.87, respectively.

What to know: While the technique shows diagnostic potential, these results represent an early-stage discovery cohort requiring further clinical validation in larger patient populations. Patients experiencing fertility issues should consult a medical professional for clinical evaluation and personal advice.

Source Nature Health Sciences — nature.com/articles/s41467-026-79570-x ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.